Back to Agenda
Session 22: Postmarketing Safety Principles and Spontaneous Case Reporting
Session Chair(s)
William Gregory, PhD
Senior Director, Safety and Risk Management
Pfizer Inc, United States
This session is designed to provide an overview of key safety reporting obligations associated with marketed medicinal products. Several exercises will be included.
Have an account?